Fyodor Biotechnologies Corporation is focused on the research, development and manufacturing and commercialization of innovative diagnostic and biopharmaceutical products, targeted to large emerging economies in Africa, Asia and South America. Diseases such as malaria, sleeping sickness, meningitis and typhoid fever are leading causes of morbidities and deaths in most emerging economies around the world. The most pronounced challenges in controlling these diseases is the limited availability and access to accurate, rapid, point-of-care diagnostic tools and sustained effective treatment. The firm's goal is to expand the availability and affordability of rapid diagnostics and pharmaceuticals against infectious diseases, with an initial focus on malaria.
